Conquering Diseases

Study Of An Investigational Drug Combination For Ret-Positive Advanced Non-Small Cell Lung Cancer

Description

Seeking men and women with advanced non-small cell lung cancer with a RET gene mutation for a study of adding the study drug selpercatinib to chemotherapy compared to the usual treatment.

Overview

Participants in this study will either get the usual chemotherapy (carboplatin and pemetrexed) or the study drug (selpercatinib) with the usual chemotherapy.

What we're hoping for

We are studying whether adding a study drug (selpercatinib) to the usual chemotherapy for people with advanced non-small cell lung cancer with a RET gene mutation reducing the chance of the cancer growing or spreading.

Additional Information

ClinicalTrials.gov Identifier: NCT05364645

 Principal Investigator

William  Walsh, MD

UMass Memorial Health

 Study Contact

The Cancer  Research Office

508-856-3216

Cancer.research@umassmed.edu

 Location

UMMS University Campus

55 Lake Ave North 

Worcester,MA 01655

508-856-8989